Recursion names Vicki Goodman as CMO
Source: SeekingAlpha
2026-03-25 08:44:57 ET
More on Recursion Pharmaceuticals
- Recursion Pharmaceuticals, Inc. (RXRX) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
- Recursion Pharmaceuticals, Inc. (RXRX) Presents at Leerink Global Healthcare Conference 2026 Transcript
- Recursion Pharmaceuticals, Inc. (RXRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- Recursion outlines extended cash runway into early 2028 as platform efficiency accelerates
- Recursion jumps after solid Q4 beat
Read the full article on Seeking Alpha
For further details see:
Recursion names Vicki Goodman as CMO
Recursion Pharmaceuticals Inc.
NASDAQ: RXRX
RXRX Trading
4.15% G/L:
$3.385 Last:
4,259,762 Volume:
$3.25 Open:
RXRX Latest News
March 31, 2026 09:00:00 am
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech PlatformMarch 25, 2026 07:59:00 am
Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical OfficerRXRX Stock Data
$2,001,374,702
484,488,629
1.68%
137
N/A
Biotechnology & Life Sciences
Healthcare
US
Salt Lake City
